OBJECTIVE: To investigate the value of Compound Xuanju Capsule in the treatment of type-III prostatitis-related sexual dysfunction.
METHODS: We randomly divided 90 type-III prostatitis patients with sexual dysfunction diagnosed by NIH clinical criteria into an experiment group and a control group to be treated with Compound Xuanju Capsule and antibiotics, respectively. We analyzed the therapeutic results based on the scores on chronic prostatitis symptom index (CPSI), prostatitis-related sexual function index (PSFI ) and self-rating anxiety scale (SAS), and compared them between the two groups and with the baseline data.
RESULTS: The degree of prostatitis-related sexual dysfunction was not correlated with that of prostatitis symptoms. Prostatitis symptoms and sexual function were significantly improved in the experiment group than in the control (P < 0.05), and the SAS score was markedly lower in the former than in the latter (P < 0.05).
CONCLUSION: Compound Xuanju Capsule can not only alleviate the symptoms of type-III prostatitis, but also improve its related sexual dysfunction and anxiety.
Written by:
Li XD, Shao HL, Song GJ, Chang YH, Li XL, Wang LN, Wang L, Wei S. Are you the author?
Department of Urology, Binzhou People's Hospital, Binzhou, Shandong 256600, China.
Reference: Zhonghua Nan Ke Xue. 2012 Jul;18(7):665-8.
PubMed Abstract
PMID: 22994055
Article in Chinese.
UroToday.com Prostatitis Section
